Figure 3.
(A) Survival curves after 8 administrations of Dex 5%, free gemcitabine (Gem), squalenoyl–gemcitabine/edelfosine nanoassemblies (SQ–Gem/EF NAs) or SQ–Gem NAs at 38 μmol/kg (Eq. to EF, SQ–Gem and Gem) in tumor-bearing mice; (B) body-weight change over time (days). Values are means ± SD (n = 7), * p < 0.05.
